| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
9 Meters Biopharma Inc (NASDAQ: NMTR)
NMTR Technical Analysis
5
| As on 26th Sep 2023 NMTR STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.03 & Strong Sell for SHORT-TERM with Stoploss of 0.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NMTRSTOCK Price
| Open | 0.02 | Change | Price | % |
| High | 0.02 | 1 Day | 0.00 | 0.00 |
| Low | 0.01 | 1 Week | 0.01 | 100.00 |
| Close | 0.02 | 1 Month | 0.00 | 0.00 |
| Volume | 184336 | 1 Year | -0.57 | -96.61 |
| 52 Week High 2.92 | 52 Week Low 0.01 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 118.65 | 1.71% |
| TNXP | 0.15 | -21.05% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| BHAT | 0.04 | -20.00% |
| PONO | 1.72 | 2.38% |
| TELL | 1.00 | 0.00% |
| PLUG | 1.95 | 4.84% |
| LCID | 2.93 | 4.64% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NMTR Daily Charts |
NMTR Intraday Charts |
Whats New @ Bazaartrend |
NMTR Free Analysis |
|
|
NMTR Important Levels Intraday
| RESISTANCE | 0.04 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| SUPPORT | 0.01 |
| SUPPORT | 0.01 |
| SUPPORT | 0.01 |
| SUPPORT | 0.00 |
NMTR Forecast February 2025
| 4th UP Forecast | 0.46 |
| 3rd UP Forecast | 0.32 |
| 2nd UP Forecast | 0.23 |
| 1st UP Forecast | 0.15 |
| 1st DOWN Forecast | -0.11 |
| 2nd DOWN Forecast | -0.19 |
| 3rd DOWN Forecast | -0.28 |
| 4th DOWN Forecast | -0.42 |
NMTR Weekly Forecast
| 4th UP Forecast | 0.21 |
| 3rd UP Forecast | 0.15 |
| 2nd UP Forecast | 0.11 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | -0.03 |
| 2nd DOWN Forecast | -0.07 |
| 3rd DOWN Forecast | -0.11 |
| 4th DOWN Forecast | -0.17 |
NMTR Forecast2025
| 4th UP Forecast | 7.13 |
| 3rd UP Forecast | 4.85 |
| 2nd UP Forecast | 3.44 |
| 1st UP Forecast | 2.03 |
| 1st DOWN Forecast | -1.99 |
| 2nd DOWN Forecast | -3.4 |
| 3rd DOWN Forecast | -4.81 |
| 4th DOWN Forecast | -7.09 |
9 Meters Biopharma Inc ( NASDAQ USA Symbol : NMTR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NMTR Business Profile
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on patients with rare and unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS) and celiac disease, as well as for undisclosed rare diseases and/or unmet needs. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease; and NM-002, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that is in Phase 2 clinical trial to treat SBS. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. 9 Meters Biopharma, Inc. has a collaboration with the Duke Clinical Research Institute to support the clinical development of NM-002. The company is headquartered in Raleigh, North Carolina. Address: 8480 Honeycutt Road, Raleigh, NC, United States, 27615
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service